Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2023-04-17 | Dr. Beers received her Ph.D. in Immunology from the University of Washington. |
| 2024-04-19 | Dr. Beers has served as the Chief Scientific Officer at Tizona Therapeutics, Inc., a privately held biotechnology company, since June 2019, bringing to the role 30 years of experience in immunology and cancer research, drug development and scientific strategy and leadership. |
Data sourced from SEC filings. Last updated: 2025-10-11